Company intelligence
BLOODPAC
Accelerating the development and validation of liquid biopsy to improve the outcomes of patients with cancer.
Biotechnology Research
Chicago, US
14 employees
Founded 2017
2 public signals
About BLOODPAC
Our mandate is to accelerate the development and validation of liquid biopsy assays to improve the outcomes of patients with cancer. To do so we developed the BLOODPAC Data Commons that enables sharing of information between stakeholders in industry, academia, and regulatory agencies.
Verified activity
Signals from BLOODPAC
2 published signals
Presence & Recognition
BLOODPAC is hosting its Q3 2026 in-person meeting in Chicago on September 9–10 for discussion, collaboration, and progress across initiatives.
Reported by BLOODPAC
Presence & Recognition
BLOODPAC welcomed the Josep Carreras Leukaemia Research Institute (IJC) as its newest member.
Reported by BLOODPAC